Market Tracker

05/27 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

150.42
Delayed Data
As of May 27
 +2.25 / +1.52%
Today’s Change
124.16
Today|||52-Week Range
208.88
-21.14%
Year-to-Date
3 Biotech Stocks to Buy in June
May 27 / MotleyFool.com - Paid Partner Content
Baron Funds Comments on Alexion Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
Frank Sands Sells Visa, Baidu, Alibaba
May 24 / GuruFocus News - Paid Partner Content
Baron Funds Comments on Alexion Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close148.17
Today’s open148.20
Day’s range146.55 - 150.65
Volume1,094,251
Average volume (3 months)1,687,881
Market cap$32.9B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)+22.44%
Revenue growth (last year)+12.25%
P/E ratio230.1
Price/Sales16.57
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
SHPGShire-3.29-1.73%
ZTSZoetis Inc-0.15-0.32%
VRTXVertex Pharmaceutica...+1.19+1.33%
MYLMylan NV+0.20+0.47%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts